Brief: Jounce Says Termination Of Proposed Business Combination With Redx Pharma PLC

Redx Pharma

03/04/2023 07:05

April 3 (Reuters) - Jounce Therapeutics Inc  JNCE.O :
    * TERMINATION OF PROPOSED BUSINESS COMBINATION OF JOUNCE
THERAPEUTICS, INC. AND REDX PHARMA PLC
    * JOUNCE HAS CONFIRMED THAT IT DOES NOT WISH TO SWITCH TO A
CONTRACTUAL TAKEOVER OFFER
    * JOUNCE'S BOARD OF DIRECTORS HAS WITHDRAWN ITS
RECOMMENDATION TO
PROCEED WITH REDX BUSINESS COMBINATION
    * JOUNCE BELIEVES IT IS UNLIKELY THAT JOUNCE STOCKHOLDERS
WOULD
SUPPORT REDX BUSINESS COMBINATION
    * JOUNCE HAS CONFIRMED THAT IT DOES NOT WISH TO SWITCH TO A
CONTRACTUAL TAKEOVER OFFER
    * JOUNCE'S DECISION WAS BASED UPON RECEIPT OF AN UNSOLICITED
PROPOSAL FROM CONCENTRA BIOSCIENCES

Source text for Eikon:  ID:nGNX8VMLTv 
Further company coverage:  JNCE.O 

 ((Reuters.Briefs@thomsonreuters.com;))